Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 7584691, 10 pages
https://doi.org/10.1155/2017/7584691
Research Article

Resveratrol Prevents ROS-Induced Apoptosis in High Glucose-Treated Retinal Capillary Endothelial Cells via the Activation of AMPK/Sirt1/PGC-1α Pathway

1Department of Ophthalmology, Lishui Central Hospital, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China
2Department of Ophthalmology, Lishui Hospital Affiliated with Zhejiang University, Lishui, China
3Department of Stomatology, Lishui Hospital Affiliated with Zhejiang University, Lishui, China

Correspondence should be addressed to Peipei Wang

Received 15 May 2017; Revised 17 July 2017; Accepted 6 August 2017; Published 29 October 2017

Academic Editor: Giuseppe Valacchi

Copyright © 2017 Jun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. N. Frank, “Diabetic retinopathy,” The New England Journal of Medicine, vol. 350, no. 1, pp. 48–58, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Cheung, P. Mitchell, and T. Y. Wong, “Diabetic retinopathy,” The Lancet, vol. 376, no. 9735, pp. 124–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. S. Bharadwaj, B. Appukuttan, P. A. Wilmarth et al., “Role of the retinal vascular endothelial cell in ocular disease,” Progress in Retinal and Eye Research, vol. 32, no. 1, pp. 102–180, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Behl, P. Krothapalli, T. Desta, A. DiPiazza, S. Roy, and D. T. Graves, “Diabetes-enhanced tumor necrosis factor-α production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy,” The American Journal of Pathology, vol. 172, no. 5, pp. 1411–1418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Barber, T. W. Gardner, and S. F. Abcouwer, “The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 52, no. 2, pp. 1156–1163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Yatoh, M. Mizutani, T. Yokoo et al., “Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy,” Diabetes/Metabolism Research and Reviews, vol. 22, no. 1, pp. 38–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. He, Z. Luan, X. Fu, and X. Xu, “Overexpression of uncoupling protein 2 inhibits the high glucose-induced apoptosis of human umbilical vein endothelial cells,” International Journal of Molecular Medicine, vol. 37, no. 3, pp. 631–638, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Vazquez, J. H. Lim, H. Chim et al., “PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress,” Cancer Cell, vol. 23, no. 3, pp. 287–301, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Garcia-Quintans, C. Sanchez-Ramos, I. Prieto et al., “Oxidative stress induces loss of pericyte coverage and vascular instability in PGC-1α-deficient mice,” Angiogenesis, vol. 19, no. 2, pp. 217–228, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Garcia-Quintans, I. Prieto, C. Sanchez-Ramos et al., “Regulation of endothelial dynamics by PGC-1α relies on ROS control of VEGF-A signaling,” Free Radical Biology & Medicine, vol. 93, pp. 41–51, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Garcia-Quintans, C. Sanchez-Ramos, A. Tierrez et al., “Control of endothelial function and angiogenesis by PGC-1α relies on ROS control of vascular stability,” Free Radical Biology & Medicine, vol. 75, article S5, Supplement 1, 2014. View at Publisher · View at Google Scholar
  14. D. G. Hardie, J. W. Scott, D. A. Pan, and E. R. Hudson, “Management of cellular energy by the AMP-activated protein kinase system,” FEBS Letters, vol. 546, no. 1, pp. 113–120, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. G. Hardie, “AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 774–785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kubota, Y. Ozawa, T. Kurihara et al., “Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation,” Investigative Ophthalmology & Visual Science, vol. 52, no. 12, pp. 9142–9148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Vingtdeux, P. Chandakkar, H. Zhao, C. d'Abramo, P. Davies, and P. Marambaud, “Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation,” The FASEB Journal, vol. 25, no. 1, pp. 219–231, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Zheng, H. Chen, J. Li et al., “Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin,” Diabetes, vol. 61, no. 1, pp. 217–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. S. Leonard, C. Xia, B. H. Jiang et al., “Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses,” Biochemical and Biophysical Research Communications, vol. 309, no. 4, pp. 1017–1026, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Zeng, Y. Wang, N. Yang et al., “Resveratrol inhibits diabetic-induced Müller cells apoptosis through microRNA-29b/specificity protein 1 pathway,” Molecular Neurobiology, vol. 54, no. 6, pp. 4000–4014, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Timmers, M. K. Hesselink, and P. Schrauwen, “Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?” Annals of the New York Academy of Sciences, vol. 1290, no. 1, pp. 83–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. N. G. Vallianou, A. Evangelopoulos, and C. Kazazis, “Resveratrol and diabetes,” The Review of Diabetic Studies, vol. 10, no. 4, pp. 236–242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. P. K. Bagul and S. K. Banerjee, “Application of resveratrol in diabetes: rationale, strategies and challenges,” Current Molecular Medicine, vol. 15, no. 4, pp. 312–330, 2015. View at Publisher · View at Google Scholar
  24. N. L. Price, A. P. Gomes, A. J. Ling et al., “SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function,” Cell Metabolism, vol. 15, no. 5, pp. 675–690, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Kitada, S. Kume, N. Imaizumi, and D. Koya, “Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway,” Diabetes, vol. 60, no. 2, pp. 634–643, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Cui, X. Xu, H. Bi et al., “Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy,” Experimental Eye Research, vol. 83, no. 4, pp. 807–816, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Y. Kim, J. H. Lim, H. H. Youn et al., “Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice,” Diabetologia, vol. 56, no. 1, pp. 204–217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Cai, L. Bao, J. Ren, Y. Li, and Z. Zhang, “Grape seed procyanidin B2 protects podocytes from high glucose-induced mitochondrial dysfunction and apoptosis via the AMPK-SIRT1-PGC-1α axis in vitro,” Food & Function, vol. 7, no. 2, pp. 805–815, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. K. K. Abu-Amero, A. A. Kondkar, and K. V. Chalam, “Resveratrol and ophthalmic diseases,” Nutrients, vol. 8, no. 4, p. 200, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. M. M. Hartge, U. Kintscher, and T. Unger, “Endothelial dysfunction and its role in diabetic vascular disease,” Endocrinology and Metabolism Clinics of North America, vol. 35, no. 3, pp. 551–560, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Arunachalam, S. M. Samuel, I. Marei, H. Ding, and C. R. Triggle, “Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1,” British Journal of Pharmacology, vol. 171, no. 2, pp. 523–535, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Nita and A. Grzybowski, “The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3164734, 23 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Zheng, H. Chen, H. Wang et al., “Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor γ coactivator 1α,” Diabetes, vol. 59, no. 9, pp. 2315–2325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Ghadiri Soufi, E. Arbabi-Aval, M. Rezaei Kanavi, and H. Ahmadieh, “Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats,” Clinical and Experimental Pharmacology and Physiology, vol. 42, no. 1, pp. 63–68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. F. G. Soufi, D. Mohammad-Nejad, and H. Ahmadieh, “Resveratrol improves diabetic retinopathy possibly through oxidative stress – nuclear factor κB – apoptosis pathway,” Pharmacological Reports, vol. 64, no. 6, pp. 1505–1514, 2012. View at Publisher · View at Google Scholar
  36. H. E. Phyu, J. C. Irwin, R. K. Vella, and A. S. Fenning, “Resveratrol shows neuronal and vascular-protective effects in older, obese, streptozotocin-induced diabetic rats,” The British Journal of Nutrition, vol. 115, no. 11, pp. 1911–1918, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Hu and B. Liu, “Resveratrol via activation of LKB1-AMPK signaling suppresses oxidative stress to prevent endothelial dysfunction in diabetic mice,” Clinical and Experimental Hypertension, vol. 38, no. 4, pp. 381–387, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. R. I. Tennen, E. Michishita-Kioi, and K. F. Chua, “Finding a target for resveratrol,” Cell, vol. 148, no. 3, pp. 387–389, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. J. H. Um, S. J. Park, H. Kang et al., “AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol,” Diabetes, vol. 59, no. 3, pp. 554–563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Yan, H. Zhang, P. Liu et al., “Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart,” Basic Research in Cardiology, vol. 108, no. 3, p. 329, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Jager, C. Handschin, J. St-Pierre, and B. M. Spiegelman, “AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 29, pp. 12017–12022, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Cantó and J. Auwerx, “AMP-activated protein kinase and its downstream transcriptional pathways,” Cellular and Molecular Life Sciences, vol. 67, no. 20, pp. 3407–3423, 2010. View at Publisher · View at Google Scholar · View at Scopus